Skip to main content

Table 1 Study demographics of the AB128 study subjects a

From: Association between cell-bound blood amyloid-β(1 - 40) levels and hippocampus volume

 

HC

MCI

AD

Number of subjects

49

33

14

Age (yr)

56.2 (5.6)

74.6 (6.4)

79.5 (5.3)

Education (% >8 yr)

94

33

64

Gender (% males)

26.5

27.3

28.6

ApoE (% ε4 allele)

64.3

57.6

64.3

Creatinine (mg/dl)

0.77 (0.11)

0.83 (0.2)

0.89 (0.27)

DA Aβ(1 - 40) (pg/ml)

38.9 (10.5)

58.1 (16.3)

50.3 (18.7)

TP Aβ(1 - 40) (pg/ml)

83.3 (18.0)

93.0 (16.3)

93.8 (19.5)

CP Aβ(1 - 40) (pg/ml)

58.0 (10.3)

55.0 (14.1)

64.4 (10.7)

DA Aβ(1 - 42) (pg/ml)

13.5 (14.8)

12.1 (15.0)

12.4 (9.4)

TP Aβ(1 - 42) (pg/ml)

52.2 (33.5)

49.7 (40.9)

55.8 (30.4)

CP Aβ(1 - 42) (pg/ml)

164.6 (77.0)

154.6 (71.1)

163.3 (54.5)

  1. aAD: Alzheimer’s disease; ApoE: Apolipoprotein E; Aβ: Amyloid- β CP: Cellular pellet; DA: Directly accessible; HC: Healthy control; MCI: Mild cognitive impairment; RP: Recovered from plasma; TP: Total in plasma. Mean value is the number reported and the standard deviation is in brackets, as applicable.